BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30328073)

  • 1. Investigation of the quantitative accuracy of low-dose amyloid and tau PET imaging.
    Nai YH; Watanuki S; Tashiro M; Okamura N; Watabe H
    Radiol Phys Technol; 2018 Dec; 11(4):451-459. PubMed ID: 30328073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracer Kinetic Analysis of (S)-¹⁸F-THK5117 as a PET Tracer for Assessing Tau Pathology.
    Jonasson M; Wall A; Chiotis K; Saint-Aubert L; Wilking H; Sprycha M; Borg B; Thibblin A; Eriksson J; Sörensen J; Antoni G; Nordberg A; Lubberink M
    J Nucl Med; 2016 Apr; 57(4):574-81. PubMed ID: 26795290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351.
    Lockhart SN; Baker SL; Okamura N; Furukawa K; Ishiki A; Furumoto S; Tashiro M; Yanai K; Arai H; Kudo Y; Harada R; Tomita N; Hiraoka K; Watanuki S; Jagust WJ
    PLoS One; 2016; 11(6):e0158460. PubMed ID: 27355840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [
    Shidahara M; Thomas BA; Okamura N; Ibaraki M; Matsubara K; Oyama S; Ishikawa Y; Watanuki S; Iwata R; Furumoto S; Tashiro M; Yanai K; Gonda K; Watabe H
    Ann Nucl Med; 2017 Aug; 31(7):563-569. PubMed ID: 28639126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Comparison of Tau Radioligands
    Betthauser TJ; Lao PJ; Murali D; Barnhart TE; Furumoto S; Okamura N; Stone CK; Johnson SC; Christian BT
    J Nucl Med; 2017 Jun; 58(6):996-1002. PubMed ID: 27856627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Characterization and Quantification of Neurofibrillary Tau PET Radioligand
    Betthauser TJ; Cody KA; Zammit MD; Murali D; Converse AK; Barnhart TE; Stone CK; Rowley HA; Johnson SC; Christian BT
    J Nucl Med; 2019 Jan; 60(1):93-99. PubMed ID: 29777006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    Baker SL; Lockhart SN; Price JC; He M; Huesman RH; Schonhaut D; Faria J; Rabinovici G; Jagust WJ
    J Nucl Med; 2017 Feb; 58(2):332-338. PubMed ID: 27587706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Takahashi M; Nakagawara J; Iida H; Kishimoto T; Nagatsuka K
    Neuroimage Clin; 2017; 13():209-214. PubMed ID: 28003959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Quantification of Tau Pathology in Human Brain with 11C-PBB3.
    Kimura Y; Ichise M; Ito H; Shimada H; Ikoma Y; Seki C; Takano H; Kitamura S; Shinotoh H; Kawamura K; Zhang MR; Sahara N; Suhara T; Higuchi M
    J Nucl Med; 2015 Sep; 56(9):1359-65. PubMed ID: 26182966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of tau PET tracers
    Chen J; Li Y; Pirraglia E; Okamura N; Rusinek H; de Leon MJ;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1596-1604. PubMed ID: 29704038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [
    Jonasson M; Wall A; Chiotis K; Leuzy A; Eriksson J; Antoni G; Nordberg A; Lubberink M
    Neuroimage Clin; 2019; 22():101681. PubMed ID: 30710871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centiloid scale analysis for
    Yamao T; Miwa K; Wagatsuma K; Shigemoto Y; Sato N; Akamatsu G; Ito H; Matsuda H
    Phys Med; 2021 Feb; 82():249-254. PubMed ID: 33677386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Dosimetry, Quantitative Methods, and Test-Retest Variability of
    Bullich S; Barret O; Constantinescu C; Sandiego C; Mueller A; Berndt M; Papin C; Perrotin A; Koglin N; Kroth H; Pfeifer A; Tamagnan G; Madonia J; Seibyl JP; Marek K; De Santi S; Dinkelborg LM; Stephens AW
    J Nucl Med; 2020 Jun; 61(6):920-927. PubMed ID: 31712324
    [No Abstract]   [Full Text] [Related]  

  • 16. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
    Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
    Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau positron emission tomography using [
    Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
    Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjects.
    Mountz JM; Laymon CM; Cohen AD; Zhang Z; Price JC; Boudhar S; McDade E; Aizenstein HJ; Klunk WE; Mathis CA
    Neuroimage Clin; 2015; 9():592-8. PubMed ID: 26640770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatially constrained kinetic modeling with dual reference tissues improves
    Zhou Y; Flores S; Mansor S; Hornbeck RC; Tu Z; Perlmutter JS; Ances B; Morris JC; Gropler RJ; Benzinger TLS
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3172-3186. PubMed ID: 33599811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.